GLI1 and breast cancer: Moreover, both 3-year survival (HR = 1.74, 95% CI: [1.28, 2.36]) and 5-year survival (HR = 2.04, 95% CI: [1.62, 2.57]) were worse in high Gli1 expression breast cancer cohort compared with low Gli1 expression cohort.